HSBC Holdings’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-42,400
Closed -$8.06M 3162
2019
Q4
$8.06M Sell
42,400
-13,600
-24% -$2.45M 0.01% 903
2019
Q3
$9.42M Sell
56,000
-77,700
-58% -$12.7M 0.02% 882
2019
Q2
$22.4M Buy
133,700
+38,900
+41% +$5.39M 0.04% 449
2019
Q1
$13.9M Buy
94,800
+66,000
+229% +$9.57M 0.03% 643
2018
Q4
$3.85M Sell
28,800
-9,200
-24% -$1.51M 0.01% 1217
2018
Q3
$7.24M Buy
38,000
+37,800
+18,900% +$6.94M 0.01% 982
2018
Q2
$33K Hold
200
﹤0.01% 2532
2018
Q1
$34K Buy
+200
New +$33.5K ﹤0.01% 2516
2017
Q4
Sell
-51,900
Closed -$10.6M 2470
2017
Q3
$10.6M Buy
51,900
+45,300
+686% +$10.5M 0.02% 774
2017
Q2
$1.6M Sell
6,600
-123,500
-95% -$29M ﹤0.01% 1331
2017
Q1
$31.1M Buy
130,100
+10,900
+9% +$2.54M 0.07% 321
2016
Q4
$25M Buy
119,200
+103,300
+650% +$21.4M 0.06% 398
2016
Q3
$3.66M Sell
15,900
-9,400
-37% -$2.3M 0.01% 1010
2016
Q2
$5.85M Buy
+25,300
New +$5.83M 0.02% 855
2016
Q1
Sell
-20,500
Closed -$6.41M 2285
2015
Q4
$6.41M Buy
+20,500
New +$6.1M 0.02% 845
2015
Q2
Sell
-1,300
Closed -$387K 2339
2015
Q1
$387K Buy
+1,300
New +$371K ﹤0.01% 1649

Other funds holding AGN

HSBC Holdings's AGN Position: Q2 2020 in Review

HSBC Holdings sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,137,094 shares — an estimated $203M sold.

HSBC Holdings first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $203M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • HSBC Holdings reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • HSBC Holdings sold 1,137,094 Allergan plc shares in Q2 2020, an estimated $203M.
  • HSBC Holdings first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
  • HSBC Holdings's Allergan plc position peaked at $203M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on HSBC Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.